Bortezomib resistance in Mantle Cell Lymphoma (MCL) is associated with plasmacytic differentiation

GSE20915

Homo sapiens

9 Downloadable Samples

Affymetrix Human Genome U133 Plus 2.0 Array (hgu133plus2)

Submitter Supplied Information

Description

Bortezomib-induced resistant MCL cell lines (HBL2 BR and JEKO BR) were generated by continuous cultured of corresponding parental cell lines (HBL2 PT and JEKO PT) with increasing bortezomib concentrations

PubMed ID

20956803

Publication Title

Bortezomib resistance in mantle cell lymphoma is associated with plasmacytic differentiation.

Total Samples

Submitter’s Institution

NHLBI-NIH

Authors

Pérez-Galán P, Mora-Jensen H, Weniger MA, Shaffer AL 3rd, Rizzatti EG, Chapman CM, Mo CC, Stennett LS, Rader C, Liu P, Raghavachari N, Stetler-Stevenson M, Yuan C, Pittaluga S, Maric I, Dunleavy KM, Wilson WH, Staudt LM, Wiestner A

Source Repository

Gene Expression Omnibus (GEO)

Alternate Accession IDs

E-GEOD-20915

No rows found